サマリー

The global artificial insemination market reached a value of US$ 2,034 Million in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 8.5% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Artificial insemination is an assisted reproductive treatment wherein semen with living sperms is introduced into the cervix, fallopian tubes, or uterus of a female. It is performed via artificial insemination homologous (AIH) or artificial insemination donor semen (AID) procedures that are short and relatively painless. Self-insemination kits are nowadays available in the market that can be used at the convenience of home. At present, artificial insemination is widely being used in animal breeding to facilitate the reproductive success and conservation of threatened or endangered species. It also prevents the spread of certain diseases and sterility due to genital conditions in animals.

Artificial Insemination Market Trends:
The rising infertility rates, along with the increasing awareness among individuals about alternative reproductive treatments, represent one of the significant factors influencing the market. Moreover, governments of numerous countries have legalized same-sex marriage and are providing insurance coverage to civil unions for artificial insemination procedures, which is also contributing to the market growth. Apart from this, the rising global population and the escalating demand for animal-based protein are fueling the need for artificial insemination among domestic livestock animals. Improving veterinary services and rising expenditure on animal healthcare is also supporting the market growth. Furthermore, the leading players are entering into strategic collaborations for expanding their portfolio of animal genetic and strengthening their position in different markets. For instance, Genus plc, which is a leading animal genetics company, partnered with Beijing Capital Agribusiness Co. Ltd, a leading Chinese animal protein genetics business, to research and develop virus-resistant techniques in pigs.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global artificial insemination market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on type, source type and end use.

Breakup by Type:

Intrauterine
Intracervical
Intravaginal
Intratubal

Breakup by Source Type:

AIH-Husband
AID-Donor

Breakup by End Use:

Hospitals and Clinics
Fertility Centers
Others

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Conceivex Inc., FUJIFILM Irvine Scientific Inc. (Fujifilm Holdings Corporation), Genea Limited, Genus plc, Hamilton Thorne Inc., Hi-Tech Solutions, Kitazato Corporation, Pride Angel, Rinovum Women’s Health LLC, Rocket Medical plc, TenderNeeds Fertility LLC and Vitrolife AB. Key Questions Answered in This Report:
How has the global artificial insemination market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global artificial insemination market?
What are the key regional markets?
What is the breakup of the market based on the type?
What is the breakup of the market based on the source type?
What is the breakup of the market based on the end use?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global artificial insemination market and who are the key players?
What is the degree of competition in the industry?

ページTOPに戻る

目次

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Artificial Insemination Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Intrauterine
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Intracervical
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Intravaginal
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Intratubal
6.4.1 Market Trends
6.4.2 Market Forecast
7 Market Breakup by Source Type
7.1 AIH-Husband
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 AID-Donor
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by End Use
8.1 Hospitals and Clinics
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Fertility Centers
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Conceivex Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.2 FUJIFILM Irvine Scientific Inc. (Fujifilm Holdings Corporation)
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Genea Limited
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 Genus plc
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Hamilton Thorne Inc.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.6 Hi-Tech Solutions
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.7 Kitazato Corporation
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 Pride Angel
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 Rinovum Women’s Health LLC
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.10 Rocket Medical plc
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.11 TenderNeeds Fertility LLC
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.12 Vitrolife AB
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 Financials